Probiotix Health PLC Change of auditor
February 09 2024 - 1:00AM
RNS Regulatory News
RNS Number : 5500C
Probiotix Health PLC
09 February 2024
ProBiotix Health
plc
("ProBiotix" or the
"Company")
Change of auditor
ProBiotix Health plc (AQUIS: PBX), a
life sciences
business developing probiotics to support
cardiometabolic health, announces the appointment of Gerald Edelman as the Company's
auditor. Gerald Edelman LLP will replace Gravita Audit Limited with
immediate effect.
The Company's previous auditor,
Gravita Audit Limited, has confirmed to the Company that it is not
aware of any circumstances connected with its termination as
auditor that it considers should be brought to the attention of the
Board, creditors or shareholders of the Company.
For further
information, please contact:
ProBiotix Health plc
|
https://probiotixhealth-ir.com/
|
Steen Andersen, Chief
Executive
|
Contact via Walbrook
below
|
|
|
Peterhouse
Capital Limited (Aquis Corporate Adviser and
Broker)
|
Tel: 020 7469
0930
|
Mark Anwyl
|
|
Duncan Vasey
|
|
|
|
Walbrook PR Ltd
|
probiotix@walbrookpr.com
|
Anna Dunphy
|
Mob: 07876
741 001
|
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
NEXUPUUAPUPCGQR
Probiotix Health (AQSE:PBX)
Historical Stock Chart
From Oct 2024 to Nov 2024
Probiotix Health (AQSE:PBX)
Historical Stock Chart
From Nov 2023 to Nov 2024